Adjuvant RT underused in prostate cancer

Despite clinical trials showing a benefit of adjuvant radiotherapy for certain men with prostate cancer, the uptake in Victoria is low, shows a cancer registry study.

Of 833 men defined as being at high risk because of at least one adverse pathology result, only 9.4% received adjuvant radiotherapy within six months of radical prostatectomy, the study authors report.

This is despite the long term